Current Ratio in % of Cytek Biosciences, Inc. from Q1 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cytek Biosciences, Inc. quarterly Current Ratio history and change rate from Q1 2022 to Q3 2025.
  • Cytek Biosciences, Inc. Current Ratio for the quarter ending September 30, 2025 was 545 %, a 20.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Cytek Biosciences, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 545 -140 -20.4% Sep 30, 2025
Q2 2025 571 -141 -19.8% Jun 30, 2025
Q1 2025 619 -107 -14.8% Mar 31, 2025
Q4 2024 654 -85.8 -11.6% Dec 31, 2024
Q3 2024 685 -108 -13.6% Sep 30, 2024
Q2 2024 712 -159 -18.3% Jun 30, 2024
Q1 2024 726 -206 -22.1% Mar 31, 2024
Q4 2023 740 -273 -27% Dec 31, 2023
Q3 2023 793 -307 -27.9% Sep 30, 2023
Q2 2023 871 -311 -26.3% Jun 30, 2023
Q1 2023 933 -206 -18.1% Mar 31, 2023
Q4 2022 1.01K Dec 31, 2022
Q3 2022 1.1K Sep 30, 2022
Q2 2022 1.18K Jun 30, 2022
Q1 2022 1.14K Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.